{"id":"W4220976352","doi":"10.1186/s10194-021-01378-5","title":"Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)","year":2022,"lang":"en","type":"article","venue":"The Journal of Headache and Pain","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"Broadcom (Canada); Vancouver Coastal Health","funders":"Biohaven Pharmaceuticals","keywords":"Medicine; Migraine; Post-hoc analysis; Quality of life (healthcare); Post hoc; Open label; Internal medicine; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005132747,0.0008750987,0.001633157,0.0004632913,0.0002948,0.0009205478,0.0006166374,0.0005748697,0.003495911],"category_scores_gemma":[0.005213689,0.0003599603,0.004492254,0.000763567,0.0005040334,0.0005199197,0.0004702752,0.000932692,0.0003695815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006042263,"about_ca_system_score_gemma":0.0006987319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001276462,"about_ca_topic_score_gemma":0.001937083,"domain_scores_codex":[0.9966459,0.001948215,0.0002620516,0.0005214736,0.000419158,0.0002031897],"domain_scores_gemma":[0.9934508,0.003243982,0.001932889,0.0007019464,0.0004100844,0.0002602983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7591337,0.004214395,0.1569479,0.002358386,0.04515278,0.0002280133,0.0001801927,0.001882472,0.004603026,0.00006928053,0.001646321,0.0235834],"study_design_scores_gemma":[0.08233602,0.09582674,0.7696673,0.0001807069,0.04139064,0.0005122189,0.0001703667,0.00394341,0.003266084,0.0002281392,0.002369873,0.0001086552],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933951,0.001824654,0.0004567743,0.00005478791,0.00002989792,0.0004434899,0.003128649,0.00002889536,0.0006377461],"genre_scores_gemma":[0.9952183,0.0003944736,0.0003795284,0.00007581097,0.00004237004,0.0003641721,0.00309496,0.0000121451,0.0004182475],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005132747,"threshold_uncertainty_score":0.02714491,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1225187550885521,"score_gpt":0.3586473408914869,"score_spread":0.2361285858029348,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}